Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
MRO Marathon Oil	$28.55	$28.18	$25.54 ▼ $29.74	$15.97B	2.16	5.92 million shs	N/A
NTRS Northern Trust	$127.93 +0.7%	$114.63	$80.81 ▼ $133.00	$24.89B	1.26	1.43 million shs	1.38 million shs
PFE Pfizer	$24.46 -0.5%	$24.02	$20.92 ▼ $31.54	$139.06B	0.58	41.93 million shs	36.27 million shs

(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
MRO Marathon Oil	0.00%	0.00%	0.00%	0.00%	-1.92%
NTRS Northern Trust	+1.80%	+0.35%	+15.90%	+43.91%	+47.47%
PFE Pfizer	+0.02%	-4.55%	+2.46%	+11.14%	-18.07%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
MRO Marathon Oil	0.5975 of 5 stars	1.2	0.0	2.5	0.0	0.0	1.7	1.3
NTRS Northern Trust	4.1216 of 5 stars	2.0	5.0	2.5	0.0	4.0	2.5	2.5
PFE Pfizer	4.9633 of 5 stars	3.2	3.0	4.2	4.5	2.6	1.7	3.1

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
MRO Marathon Oil	2.40	Hold	$30.50	6.83% Upside
NTRS Northern Trust	1.92	Reduce	$114.50	-9.92% Downside
PFE Pfizer	2.45	Hold	$28.55	16.94% Upside

Current Analyst Ratings Breakdown

Latest NTRS, PFE, and MRO Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/11/2025	NTRS Northern Trust	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Market Perform ➝ Underperform	$103.00 ➝ $120.00
7/3/2025	NTRS Northern Trust	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Hold ➝ Hold	$116.00 ➝ $126.00
7/2/2025	NTRS Northern Trust	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Sell ➝ Sell	$89.00 ➝ $101.00
7/2/2025	NTRS Northern Trust	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	In-Line ➝ In-Line	$108.00 ➝ $121.00
7/1/2025	NTRS Northern Trust	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Underweight ➝ Underweight	$103.00 ➝ $106.00
6/30/2025	NTRS Northern Trust	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Outperform ➝ Outperform	$123.00
6/3/2025	NTRS Northern Trust	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Underweight ➝ Underweight	$101.00 ➝ $103.00
5/29/2025	PFE Pfizer	Berenberg Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold	$28.00 ➝ $25.00
5/21/2025	PFE Pfizer	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy	$32.00 ➝ $33.00
5/19/2025	PFE Pfizer	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy	$27.00 ➝ $26.00
4/30/2025	PFE Pfizer	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Underperform	$22.00 ➝ $23.00

(Data available from 7/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
MRO Marathon Oil	$6.70B	2.38	$6.49 per share	4.40	$20.44 per share	1.40
NTRS Northern Trust	$16.06B	1.54	$11.68 per share	10.88	$60.05 per share	2.12
PFE Pfizer	$63.63B	2.18	$4.33 per share	5.64	$15.62 per share	1.56

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
MRO Marathon Oil	$1.55B	$2.33	12.25	12.92	N/A	19.73%	12.80%	7.35%	N/A
NTRS Northern Trust	$2.03B	$10.72	11.87	14.08	1.85	13.93%	13.73%	1.03%	7/23/2025 (Estimated)
PFE Pfizer	$8.03B	$1.38	17.69	8.06	0.90	12.62%	20.33%	8.53%	8/5/2025 (Estimated)

Latest NTRS, PFE, and MRO Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/5/2025	Q2 2025	PFE Pfizer	$0.57	N/A	N/A	N/A	$13.43 billion	N/A
7/23/2025	Q2 2025	NTRS Northern Trust	$2.06	N/A	N/A	N/A	$1.96 billion	N/A
4/29/2025	Q1 2025	PFE Pfizer	$0.67	$0.92	+$0.25	$0.52	$14.43 billion	$13.72 billion
4/22/2025	Q1 2025	NTRS Northern Trust	$1.85	$1.90	+$0.05	$1.90	$1.95 billion	$1.95 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
MRO Marathon Oil	$0.44	1.54%	N/A	18.88%	2 Years
NTRS Northern Trust	$3.00	2.36%	N/A	27.99%	N/A
PFE Pfizer	$1.72	7.04%	N/A	124.64%	16 Years

Latest NTRS, PFE, and MRO Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
6/25/2025	PFE Pfizer	quarterly	$0.43	7.08%	7/25/2025	7/25/2025	9/2/2025
4/22/2025	NTRS Northern Trust	quarterly	$0.75	3.3%	6/6/2025	6/6/2025	7/1/2025
4/23/2025	PFE Pfizer	quarterly	$0.43	7.69%	5/9/2025	5/9/2025	6/13/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
MRO Marathon Oil	0.40	0.69	0.61
NTRS Northern Trust	0.57	0.71	0.71
PFE Pfizer	0.64	1.26	0.96

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
MRO Marathon Oil	77.24%
NTRS Northern Trust	83.19%
PFE Pfizer	68.36%

Insider Ownership

Company	Insider Ownership
MRO Marathon Oil	0.35%
NTRS Northern Trust	0.77%
PFE Pfizer	0.06%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
MRO Marathon Oil	1,681	559.41 million	557.45 million	Optionable
NTRS Northern Trust	23,300	194.54 million	193.04 million	Optionable
PFE Pfizer	81,000	5.69 billion	5.68 billion	Optionable

NTRS, PFE, and MRO Headlines

Recent News About These Companies

Pfizer (PFE) and Bristol Myers (BMY) Launch Direct-to-Patient Eliquis Program

4 hours ago | insidermonkey.com

Pfizer’s Hemophilia Study: Insights into Treatment Patterns and Outcomes

July 18 at 12:57 PM | tipranks.com

Pfizer’s BeneFIX Study Update: Key Insights for Investors

July 18 at 12:57 PM | tipranks.com

Pfizer’s INLYTA® Study in Taiwan: Key Insights for Investors

July 18 at 12:57 PM | tipranks.com

Pfizer’s Latest Study on PF-07799544: A Potential Game-Changer for Advanced Solid Tumors

July 18 at 12:08 PM | tipranks.com

Pfizer’s Rimegepant Study: A New Hope for Migraine Prevention?

July 18 at 12:08 PM | tipranks.com

Pfizer Inc. (NYSE:PFE) Shares Purchased by FLC Capital Advisors

July 18 at 11:10 AM | marketbeat.com

63,000 Shares in Pfizer Inc. (NYSE:PFE) Bought by Hussman Strategic Advisors Inc.

July 18 at 10:39 AM | marketbeat.com

Pfizer Inc. (NYSE:PFE) Shares Purchased by Alexander Labrunerie & CO. Inc.

July 18 at 9:28 AM | marketbeat.com

Bristol‑Myers Squibb, Pfizer Set To Launch Direct‑To‑Patient Eliquis At 40% Off

July 17 at 3:26 PM | benzinga.com

Trade Tracker: Josh Brown Sells Pfizer

July 17 at 2:10 PM | youtube.comY

3 Ultra-Safe Dividend Stocks That Yield Over 5%

July 17 at 11:47 AM | 247wallst.com

Bristol Myers Squibb, Pfizer to sell blockbuster blood thinner Eliquis at 40% discount

July 17 at 11:47 AM | cnbc.com

Bristol Myers, Pfizer to sell blood thinner Eliquis directly to US patients

July 17 at 11:18 AM | reuters.com

Pfizer Inc.'s (NYSE:PFE) recent 3.7% pullback adds to one-year year losses, institutional owners may take drastic measures

July 17 at 11:18 AM | finance.yahoo.com

Bristol-Myers Squibb (BMY) and Pfizer (PFE) Stocks Jump on Eliquis Drug Discount

July 17 at 10:43 AM | tipranks.com

Mystic Asset Management Inc. Grows Position in Pfizer Inc. (NYSE:PFE)

July 17 at 9:48 AM | marketbeat.com

Bristol Myers, Pfizer to sell blood thinner Eliquis directly to patients

July 17 at 9:34 AM | investing.com

Pzena Investment Management LLC Increases Position in Pfizer Inc. (NYSE:PFE)

July 17 at 9:22 AM | marketbeat.com

Commerzbank Aktiengesellschaft FI Trims Stock Position in Pfizer Inc. (NYSE:PFE)

July 17 at 9:14 AM | marketbeat.com

Easterly Investment Partners LLC Increases Stock Holdings in Pfizer Inc. (NYSE:PFE)

July 17 at 9:00 AM | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Why BigBear.ai Could Rally 100% and Catch Palantir Soon
By Gabriel Osorio-Mazilli | June 30, 2025
View Why BigBear.ai Could Rally 100% and Catch Palantir Soon
3 Defense Leaders Set to Gain From Rising Military Spend
By Chris Markoch | July 5, 2025
View 3 Defense Leaders Set to Gain From Rising Military Spend
IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge
By Dan Schmidt | June 20, 2025
View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge
BigBear.ai Poised to Benefit as Palantir Dominates AI Defense
By Gabriel Osorio-Mazilli | June 23, 2025
View BigBear.ai Poised to Benefit as Palantir Dominates AI Defense
Top 5 Undervalued Dividend Stocks With Strong Payout Potential
By Ryan Hasson | July 7, 2025
View Top 5 Undervalued Dividend Stocks With Strong Payout Potential

NTRS, PFE, and MRO Company Descriptions

Marathon Oil NYSE:MRO

Marathon Oil Corporation, an independent exploration and production company, engages in exploration, production, and marketing of crude oil and condensate, natural gas liquids, and natural gas in the United States and internationally. The company also produces and markets products manufactured from natural gas, such as liquefied natural gas and methanol. In addition, it owns and operates Sugarloaf gathering system, a natural gas pipeline. The company was formerly known as USX Corporation and changed its name to Marathon Oil Corporation in December 2001. Marathon Oil Corporation was founded in 1887 and is headquartered in Houston, Texas.

Northern Trust NASDAQ:NTRS

$127.93 +0.87 (+0.68%)

Closing price 04:00 PM Eastern

Extended Trading

$127.93 0.00 (0.00%)

As of 06:01 PM Eastern

Northern Trust Corporation, a financial holding company, provides wealth management, asset servicing, asset management, and banking solutions for corporations, institutions, families, and individuals worldwide. It operates in two segments, Asset Servicing and Wealth Management. The Asset Servicing segment offers asset servicing and related services, including custody, fund administration, investment operations outsourcing, investment management, investment risk and analytical services, employee benefit services, securities lending, foreign exchange, treasury management, brokerage services, transition management services, banking, and cash management services. This segment serves corporate and public retirement funds, foundations, endowments, fund managers, insurance companies, sovereign wealth funds, and other institutional investors. The Wealth Management segment offers trust, investment management, custody, and philanthropic; financial consulting; guardianship and estate administration; family business consulting; family financial education; brokerage services; and private and business banking services. This segment serves high-net-worth individuals and families, business owners, executives, professionals, retirees, and established privately held businesses. The company also provides asset management services, such as active and passive equity; active and passive fixed income; cash management; muti-asset and alternative asset classes comprising private equity and hedge funds of funds; and multi-manager advisory services and products through separately managed accounts, bank common and collective funds, registered investment companies, exchange traded funds, non-U.S. collective investment funds, and unregistered private investment funds. In addition, it offers overlay and other risk management services. Northern Trust Corporation was founded in 1889 and is headquartered in Chicago, Illinois.

Pfizer NYSE:PFE

$24.46 -0.12 (-0.49%)

Closing price 03:59 PM Eastern

Extended Trading

$24.48 +0.02 (+0.10%)

As of 06:41 PM Eastern

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time